Last reviewed · How we verify
Malignant tumor of testis
Approved treatments
- Mithramycin A
- Vepesid · Bristol-Myers Squibb K.K.
- Mithramycin · National Cancer Institute (NCI)
- Vinblastin · The Lymphoma Academic Research Organisation
- Cosmegen · Recordati
Dactinomycin binds DNA and inhibits RNA synthesis, demonstrating cytotoxic activity in cancer models. - Etoposid · University of Ulm
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Malignant tumor of testis patent landscape — cliff calendar, originator estates, attackable patents
- Malignant tumor of testis treatment landscape brief
- Malignant tumor of testis treatment updates RSS
Frequently asked questions about Malignant tumor of testis
What drugs treat Malignant tumor of testis?
Tracked treatments include Mithramycin A, Vepesid, Mithramycin, Vinblastin, Cosmegen, Etoposid.
What is the treatment for Malignant tumor of testis?
Standard treatment for Malignant tumor of testis includes Mithramycin A, Vepesid, Mithramycin, Vinblastin, Cosmegen. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Malignant tumor of testis patent cliff · Malignant tumor of testis CI report
- Treatment: Mithramycin A
- Treatment: Vepesid · Bristol-Myers Squibb K.K.
- Treatment: Mithramycin · National Cancer Institute (NCI)
- Treatment: Vinblastin · The Lymphoma Academic Research Organisation
- Treatment: Cosmegen · Recordati
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing